ClearB Therapeutics Licenses Novel Saponin Adjuvant TQL-1055, to Present Hepatitis B Vaccine Data at AASLD 2024 ClearB Therapeutics, a company focused on developing therapeutic vaccines for a functional cure of…
Life Sciences Experts to Explore Global Collaboration, AI, and Clinical Trial Innovation at DIA Canada Annual Meeting The upcoming DIA Canada Annual Meeting, taking place on November 14-15 in Gatineau,…
CareSource and Nomi Health Partner to Improve Healthcare Access for Medicaid Members CareSource, a nonprofit health plan serving over 2 million members, has partnered with Nomi Health to launch a…
Komodo Health Unveils National Drug Projections for Real-Time Prescription Insights Komodo Health has launched its new product, National Drug Projections, offering a comprehensive view of prescription trends across the U.S.…
Clarametyx Biosciences Moves Forward with Phase 2a Study of CMTX-101 for Cystic Fibrosis Infections Clarametyx Biosciences, Inc. has successfully completed the Phase 1b portion of its clinical trial for CMTX-101,…
ModMed Empowers Ophthalmology Practices with Innovative Solutions at AAO 2024 ModMed® is excited to announce its participation in the American Academy of Ophthalmology (AAO) 2024 conference, taking place from October…
DNA Script Appoints Marc Montserrat as CEO, Thomas Ybert Transitions to Chief Scientific Officer DNA Script, a leader in enzymatic DNA synthesis, has appointed Marc Montserrat as its new Chief…
BenevolentAI benoemt Kenneth Mulvany tot uitvoerend voorzitter om AI-gestuurde geneesmiddelenontwikkeling te versnellen BenevolentAI, een toonaangevend bedrijf dat geavanceerde AI toepast voor de ontdekking en ontwikkeling van biofarmaceutische geneesmiddelen, heeft vandaag…
Kezar Life Sciences Updates on Clinical Trials for Zetomipzomib Kezar Life Sciences, Inc. (Nasdaq: KZR), a biotechnology company focused on developing innovative therapeutics for immune-mediated diseases, has provided important updates…
The “Peripheral Vascular Devices Market Report, Forecast by Device Type, Country and Company Analysis 2024-2032” has been added to ResearchAndMarkets.com. The global peripheral vascular devices market is projected to grow…
HeartBeam Appoints Robert Eno as CEO, Focused on U.S. Commercialization Industry leader brings extensive experience in developing go-to-market strategies for breakthrough products and driving growth HeartBeam, Inc. (NASDAQ: BEAT), a…
Kezar Life Sciences Board Unanimously Rejects Concentra’s Acquisition Proposal and Implements Limited Duration Stockholder Rights Plan Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company focused on developing novel…